<DOC>
	<DOCNO>NCT01239108</DOCNO>
	<brief_summary>Dose escalation study subject Leukemia return responded standard treatment .</brief_summary>
	<brief_title>Study SGI-1776 , PIM Kinase Inhibitor , Subjects With Relapsed/Refractory Leukemias</brief_title>
	<detailed_description>A Phase 1 , Multicenter , Open-label , Dose-escalation Study SGI-1776 , PIM Kinase Inhibitor , Subjects Relapsed/Refractory Leukemias</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<criteria>1 . Men woman confirm diagnosis leukemia unresponsive curative therapy 2 . Eastern Cooperative Oncology Group performance status 0 2 3 . Total bilirubin ≤ 1.5 X upper limit normal ( ULN ) ; aspartate transaminase ( AST/SGOT ) alanine transaminase ( ALT/SGPT ) ≤ 3 X ULN ; serum creatinine ≤ 2 X ULN 4 . Normal cardiac function leave ventricular ejection fraction ≥ 50 % screen 5 . No clinically significant abnormality screen electrocardiogram ( ie , QTc interval must &lt; 470 msec woman &lt; 450 msec men history torsades de pointes ) 6 . No reproductive potential willing use 2 method contraception study 30 day last dose 7 . Able understand purpose risk study provide inform consent authorization use protect health information 1 . A lifethreatening illness , medical condition organ system dysfunction , investigator 's opinion , could compromise subject 's safety , interfere absorption metabolism oral SGI1776 , put study outcome undue risk 2 . Significant cardiovascular disease 3 . Malabsorption syndrome 4 . Symptomatic central nervous system metastases lesion treatment require 5 . Received prior radiation therapy within 4 week first dose 6 . Grade ≥ 2 toxicity ( alopecia ) continue prior anticancer therapy include radiation 7 . Treatment investigational drug within 3 week first dose 8 . Use systemic corticosteroid ( premedications intermittent dos use allergic reaction control asthma ) myelosuppressive chemotherapy within 2 week first dose treatment nitrosoureas mitomycin C within 3 week first dose SGI 1776 9 . Uncontrolled active systemic infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>